THE EFFECTS OF VITAMIN D SUPPLEMENTATION IN RESPIRATORY INDEX OF SEVERITY IN CHILDREN (RISC) OF HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL

Journal Title: Acta HealthMedica - Year 2016, Vol 1, Issue 3

Abstract

Background: Many children are affected by pneumonia and its complications annually, despite the fact that there are several known risk factors; vitamin D deficiency may play a role in this disease. Objective: The aim of this study was to determine the efficacy of vitamin D supplementation in Respiratory Index of Severity in Children (RISC) hospitalized clinical outcomes of hospitalized patients with community-acquired pneumonia. Methods: This randomized double-blind clinical trial was conducted on children from 2 months to 6 years old with pneumonia, hospitalized at Bandar Abbas Pediatric Hospital of Iran between January 2015 and 2016. Children were randomly divided into two groups of A: received vitamin D (at a dose of 50,000 IU per day for 2 days) in addition to routine treatment of pneumonia, and B: received placebo instead of vitamin D. The primary outcome was RISC alterations before and after interventions. The statistical software SPSS 16 and Chi-square and Independent Samples T tests were used for analysis. Results: One hundred patients were studied. The demographic variables were similar in two groups (P>0.05). There was no significant difference between the vitamin D group and control group in percentage of patients with wheezing (P=0.408), fever (P=0.393), retraction (P=0.146), crackles (P=0.753), tachypnea (P=0.105), and poor feeding (P=0.157). The duration of antibiotic use was significantly lower in vitamin D group (4.18 ± 1.40 versus 3.22 ± 1.32 days; P=0.001). Conclusion: According to the results, it seems that vitamin D supplementation may reduce the duration of antibiotic therapy in children with pneumonia. Clinical Trial Registration: The trial was registered at the Registry of Clinical Trials (http://www.clinicaltrials.gov) with the ID: NCT02936895

Authors and Affiliations

Mohammad Bagher Rahmati, Maryam Rezapour, Samira Zakeri Shahvari

Keywords

Related Articles

CREATING THE FIRST REGISTRY FRAMEWORK FOR COCHLEAR IMPLANTED PATIENTS IN IRAN: A PRELIMINARY REPORT

Introduction: Currently, there is a paucity of data concerning the long-term outcomes, educational placement and quality of life of cochlear implanted (CI) patients in Iran. Therefore, we decided to design a national CI...

PREVALENCE OF ASYMPTOMATIC AVASCULAR NECROSIS OF THE HIP IN PATIENTS WITH KIDNEY TRANSPLANTATION

Introduction: Kidney transplant is one of the treatments in patients with ESRD (end stage renal disease) that increases the quality of life in patients. Following kidney transplant, patients need glucocorticoid and immun...

EPIDEMIOLOGY AND FORMATION OF FUNGAL BIOFILMS AND SUSCEPTIBILITY TESTING OF CANDIDA GLABRATA ISOLATED ON ENDOSCOPES IN THE DEPARTMENT OF GASTROENTEROLOGY AT THE UNIVERSITY HOSPITAL OF TLEMCEN

Background: Candidosis is the most prevalent opportunistic fungal infection of humans. It causes a variety of damages ranging from superficial mucosal diseases to deep-seated mycoses. It represents the leading cause of i...

BIONIC EYE AND CREATE ARTIFICIAL VISION

Introduction: There are nearly 40 million cases of blindness in the worldwide, and 124 million people have been affected by low vision. For this reason, researchers are intent on developing new ways to restore vision. On...

COST-EFFECTIVENESS SIMULATION ANALYSIS OF INTERNET-BASED INSURANCE PRESCRIPTION VERIFICATION SYSTEM

Introduction: One common cited reason for investigating Internet-based systems is the capabilities of Internet interventions to reduce health services and delivery costs. The purpose of this study was to estimate the eco...

Download PDF file
  • EP ID EP343024
  • DOI 10.19082/ah60
  • Views 111
  • Downloads 0

How To Cite

Mohammad Bagher Rahmati, Maryam Rezapour, Samira Zakeri Shahvari (2016). THE EFFECTS OF VITAMIN D SUPPLEMENTATION IN RESPIRATORY INDEX OF SEVERITY IN CHILDREN (RISC) OF HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL. Acta HealthMedica, 1(3), 60-64. https://europub.co.uk/articles/-A-343024